written on 17.03.2014
Tags:
,

NICE speeds BI's Giotrif through appraisal process

TAGS: ,

NICE (National Institute for Health and Care Excellence) has recommended Giotrif for the same indication as the drug's marketing authorization: to treat adults with locally advanced or metastatic epidermal growth factor receptor tyrosine kinase (EGFR-TK)…

Latest Report